Reagun Andera’s Post

🌍 The Future Burden of Cervical and Associated Cancers in Low- and Middle-Income Countries like Nepal 🏥 Cervical cancer continues to be a significant public health challenge in low- and middle-income countries (LMICs). Despite being largely preventable through vaccination and early screening, the burden is increasing at an alarming rate. 🔑 Key Insights: Most of the cervical cancer deaths occur in LMICs. By 2030, lots of new cases are expected globally, with a high proportion in LMICs. In Nepal, cervical cancer is the second cause of cancer. HPV (Human Papillomavirus), the primary cause of cervical cancer, remains widespread, with low vaccination coverage in many developing countries. 📈 Key Trends: Increasing life expectancy is leading to a higher incidence of cancer in LMICs. Limited access to healthcare means many women are diagnosed late, resulting in poorer outcomes. Underfunded health systems and lack of routine screening programs like Pap smears and HPV vaccination leave women vulnerable. 💡 What Can Be Done? Strengthen health systems to include routine cervical cancer screenings and HPV vaccinations. Raise public awareness about HPV prevention and cancer screening. Partner with global organizations to improve healthcare access and fund life-saving initiatives. 🛑 It’s time to act before the burden becomes overwhelming. Collaborative efforts can make cervical cancer a thing of the past for future generations in LMICs like Nepal. #CervicalCancer #HPV #GlobalHealth #WomensHealth #LMICs #Nepal #PublicHealth #CancerPrevention #Healthcare #Vaccination

Cervical Cancer, the second-most common cancer among Indian women, demands our attention. In 2020 alone, there were 123,907 cases and 77,348 deaths, underscoring the urgent need for action. With a 5-year survival rate of 46%, early diagnosis is crucial. India, with 59.7 million girls and 272.8 million women in the eligible age group, is making strides towards prevention. Studies conducted across different regions of India have unveiled disparities in knowledge, attitudes, and practices regarding cervical cancer. KAP studies highlight the need for increased awareness, particularly in rural areas, where limited access to screening and low awareness levels pose significant challenges. Amidst these challenges, a beacon of hope emerges – the Indian government's groundbreaking HPV vaccination drive for girls aged 9-14. This initiative is a game-changer, recognizing and addressing disparities in knowledge, attitudes, and practices, especially in rural areas. It marks a pivotal moment in our collective fight against cervical cancer. Let's come together to raise awareness, dispel myths, and encourage preventive measures. The more we know, the better equipped we are to protect ourselves and our communities. Share this post to spread the word and be part of the change. #cervicalcancerawareness #hpvvaccination #womenhealthcare #indiaagainstcervicalcancer #femtechindia #women #india https://lnkd.in/eX4_tRZg

Startling fact: Every 8 minutes, cervical cancer claims a woman's life in India, ranking as the 2nd most common cancer among women. Lack of awareness adds to its stealth. Yet, there is hope in prevention. Through vaccination and regular screening, we have the tools to break the cycle of this silent foe. Arm yourself with awareness, choose prevention, and let's rewrite the narrative together. Know basics about Cervical Cancer: It can be prevented or detected in early stages through screening. It can be prevented through Cervical Cancer Vaccine. For corporates we are providing: 1. Workshop on Preventive Measures for Cervical Cancer from Expert Doctor 1.1> Expert-led workshops addressing the significance of cervical cancer screening for women above the age of 30 1.2> Workshops emphasizing the importance of cervical cancer vaccination for girls and women aged 9-45 2. Cervical screening for Female Employees above age of 30 Years 3. Cervical Cancer Vaccination for Female employees For all your Corporate vaccination queries, reach us on 📞 +91 8799989133 📧 enquiry@vaccineonwheels.com . . . . #JivikaHealthCare #CervicalCancer #VaccineForAll #AdultVaccine #Immuneyourself #HPVVaccine #SpreadAwareness

January is Cervical Cancer Awareness Month. According to World Health Organization, 342,000 women died from cervical cancer in 2020, with 90% of cases and deaths occurring in low and middle-income countries. Cervical cancer is the fourth most common cancer in women, and yet is one of the most successfully treatable forms of cancer. At #IWH our mission is to drive change. We encourage women to prioritize their health by undergoing screenings and receiving vaccinations. Together, let’s chart a new course and alter the trajectory of this disease for women worldwide. https://lnkd.in/eDmf5WUj #CervicalCancerAwareness #CervicalCancerMonth

Dive into the truth about cervical cancer as we debunk myths and illuminate the facts. In the pursuit of knowledge, we empower ourselves and others to navigate the path of prevention. Join the movement to break the silence surrounding this important health issue. Together, let's foster awareness and make a lasting impact on women's well-being. Know basics about Cervical Cancer: It can be prevented or detected in early stages through screening. It can be prevented thorough Cervical Cancer Vaccine. For corporates we are providing: 1. Workshop on Preventive Measures for Cervical Cancer from Expert Doctor 1.1> Expert-led workshops addressing the significance of cervical cancer screening for women above the age of 30 1.2> Workshops emphasizing the importance of cervical cancer vaccination for girls and women aged 9-45 2. Cervical screening for Female Employees above age of 30 Years 3. Cervical Cancer Vaccination for Female employees For all your Corporate vaccination queries, reach us on 📞 +91 8799989133 📧 enquiry@vaccineonwheels.com . . . . #JivikaHealthCare #CervicalCancer #VaccineForAll #AdultVaccine #Immuneyourself #HPVVaccine #SpreadAwareness

Rising from WCC 2024: The Call to Eliminate Cervical Cancer and Our First Victory Over Cancer The discussions at #WCC2024 ignited a powerful sense of hope and urgency. The path to eliminating #HPV and #cervicalcancer is clear, but it demands bold action—now. We are armed with the knowledge, technology, and tools to wipe out this preventable disease, which still claims a woman’s life every two minutes. If we do nothing, that number will rise to a woman every 90 seconds by 2050, unleashing untold devastation on families, communities, and nations alike. We have no excuse to let this happen. The tools to end these unnecessary deaths are in our hands: #HPVvaccination, #screening, and #earlytreatment. These are not just medical interventions; they are weapons in a fight we can win. The healthcare community has made strides, but that is not enough—we need a united public movement to finish this fight. The time is now to mobilize. We must arm people with the knowledge to demand the care they deserve: HPV vaccinations, self-screening for cervical cancer, and access to life-saving treatments. The HPV vaccine isn’t just a shield against cervical cancer—it prevents six different cancers across all genders. This is not a women's issue—it's a global fight that impacts us all. We must also turn our focus to low- and middle-income countries, where the toll is highest. Equity in healthcare is non-negotiable. Technology and innovation are our keys to ensuring every woman, no matter where she lives, has the same chance to live free from this disease. History has shown us the power of grassroots movements. The fight against HIV/AIDS was won through public #activism, relentless awareness, and demand for care. Now, we must spark that same fire in the battle against HPV-related cancers—starting with cervical cancer. Healthcare leaders, advocates, and the public must rise as one. Let this be our rallying cry: We will not wait. We will not lose more lives. We will make cervical cancer the first cancer we defeat. Together, we can rewrite the future, eliminating cervical cancer and ensuring a healthier world for generations to come. The time for action is now—let’s claim our first victory over cancer. #GlobalCancerMoonshot

Men's Health Week 2024 starts today. We are taking the opportunity to highlight the hugely important issue of men and cancer by launching a new report, Men and Cancer: A Charter for Action (https://lnkd.in/ejv3hy6i). This highlights the key steps that must be taken to create better cancer outcomes for men globally. Too many men are developing and dying unnecessarily from cancer. The global cancer mortality rate is 110 per 100,000, 43% higher than for women. This heavy burden has multiple causes including the failure of health promotion strategies to reach men effectively, barriers that make it harder for men to use primary care services, limited access to cancer screening services and HPV and Hepatitis B vaccination programmes, and greater exposure to carcinogens in the workplace. A previous report by GAMH, Gone Missing (https://lnkd.in/eWjg4YPh), showed that men and cancer is an issue largely unaddressed in cancer policy at the global level. The Charter calls for global action in 10 key areas, including: 1. The integration of gender into global and national cancer plans in a way that is inclusive of men. 2. The consistent collection and publication of sex-disaggregated data. 3. Cancer prevention initiatives that target men explicitly. 4. The inclusion of boys and men in vaccination programmes that can prevent cancer. 5. Improved male access to colorectal cancer screening and, as soon as possible, screening for prostate, lung and anal cancers too. 6. A sustained focus on those men at greatest risk of cancer, including men who are ethnically and racially marginalised, on low incomes, gay/bisexual/transgender or homeless. Many more male cancer cases are predicted in every continent by 2050. But this is not inevitable – the actions highlighted in GAMH’s Charter would, over time, make a significant difference. The Charter argues that cancer in men is an issue that has been neglected for too long. But we can now begin to put that right.

January marks cervical cancer awareness month and the Wellness Institute Trust (WIT) would like to take the opportunity to present a few facts. The World Health Organization (WHO) estimates cervical cancer is the fourth most common cancer in women globally. The International Agency for Research on Cancer (IARC) estimates there are 604,000 new cases and 342,000 deaths. 90% of these deaths occur in low and middle-income countries (LMIC). As we take a closer look at the region, Sub-Saharan Africa (SSA) has the highest burden of cervical cancer in the world and is the leading cause of cancer deaths in SSA accounting for approximately 15% of cancer deaths in women. Women living with HIV are six times more likely to develop cervical cancer when compared to the general population. In 2020, Kenya estimated 5,236 new cervical cancers and 3,200 deaths, which is approximately 9 deaths a day. The cause for an estimated 95% percent of cervical cancer is persistent infection of the cervix by Human Papilloma Virus (HPV). Therefore, it is imperative that protection from HPV infection is an effective method of preventing majority of cervical cancer cases. There are six safe and effective HPV vaccines available globally. It is recommended that all girls aged 9-14 should be vaccinated. Additionally, all women should be screened from the age of 30 (25 if living with HIV). Despite the availability of the HPV vaccine at no cost in Kenya, uptake has been poor. Only 33% of the target population have received the first dose, and 16% returning for the second dose. The Wellness Institute Trust is planning campaigns in multiple counties with key stakeholders to enhance awareness, dispel concerns and increase uptake of the HPV vaccine #cervicalcancer #endcervicalcancer #HPVVaccines

Inequitable access to vaccines and high-performance screening tools is hampering efforts to effectively reduce the growing burden of cervical cancer in the African region, which accounts for the highest rates of new cases and deaths due to the disease. Despite being preventable and treatable through human papillomavirus (HPV) vaccination and screening, and curable when detected early, cervical cancer remains the most common cause of cancer-related deaths in the African region. Of the more than 76 000 cervical cancer deaths globally in 2022, the most updated data available, nearly a quarter (23%) were in Africa. Read More: https://lnkd.in/dSRw8Yij “The burden of cervical cancer in Africa is a stark illustration of the impacts of global inequities, which exacerbate barriers including scarce resources, lack of prioritization by funders, and ultimately, limited capacity to manage the threat. Affordable and accessible HPV tests and vaccines are critical if we are to accelerate elimination of cervical cancer as a public health problem in the region, and narrow the wide gap in health inequality globally,” said Dr. Matshidiso Moeti , WHO’s Regional Director for Africa. #CervicalCancer #HPV #GlobalHealth #Africa #HealthcareAccess #Prevention #HealthEquity #WHO World Health Organization Duneton Philippe Unitaid

📌A Health-related Sustainability Project Did you know cervical cancer is the fourth most common cancer in women globally with around 660 000 new cases and around 350 000 deaths in 2022. (WHO, 2022). Cervical cancer ranks as the 2nd most frequent cancer among women in Nigeria and the 2nd most frequent cancer death among women between 15 and 44 years of age. The HPV types 16, 18, 31, 35, 51, 52 are all high risk and are prevalent serotypes in Nigeria with serotypes 16 and 18 responsible for 66.9% of Nigeria’s cervical cancer prevalence. (WHO, 2023) As a dedicated cervical cancer and HPV vaccine awareness advocate, I am lending my voice, hands, skills, in the fight against cervical cancer and raising awareness on HPV vaccination. Let us work together to tackle this global health threat and ensure all those who need screening and vaccination, can access them #Eliminatecervicalcancerby2030 #cervicalcancerawareness #women #girls #HPV Girlified National Primary Health Care Development Agency (NPHCDA) UNICEF World Health Organization